The ins and outs of venous access: Part I

Nutrition in Clinical Practice

Volumn 17, Issue 2, 2002, Pages 85-98

  Vanek, Vincent W ^a  

^a ST ELIZABETH HEALTH CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 18444399190     PISSN: 08845336     EISSN: None     Source Type: Journal    
DOI: 10.1177/011542650201700285     Document Type: Review

References (105)

1. Ryder M. The future of vascular access: Will the benefits be worth the risk? Nutr Clin Pract 14:165-169, 1999.
2. A.S.P.E.N. Board of Directors. Guidelines for the use of parenteral and enteral nutrition in adult and pediatric patients. JPEN 17:7SA-11SA, 1993.
3. Hadaway LC. Comparison of vascular access devices. Semin Oncol Nurs 11:154-166, 1995.
4. Ryder MA. Peripheral access options. Surg Oncol Clin N Am 4:395-427, 1995.
5. Lum PS, Soski M. Management of malpositioned central venous catheters. J Intraven Nurs 12:356-365, 1989.
6. Pearson ML. Guideline for prevention of intravascular device-related infections. Part I. Intravascular device-related infections: An overview. The Hospital Infection Control Practices Advisory Committee. Am J Infect Control 25:262-277, 1996.
7. Mequid MM, Eldar S, Wahbe A. The delivery of nutritional support: A potpourri of new devices and methods. Cancer 55:279-289, 1985.
8. Gazitua R, Wilson K, Bistrian BR, et al. Factors determining peripheral vein tolerance to amino acid infusions. Arch Surg 114:897-900, 1979.
9. Randolph AG, Cook DJ, Gonzales CA, et al. Benefit of heparin in peripheral venous and arterial catheters: Systemic review and meta-analysis of randomised controlled trials. BMJ 316:969-975, 1998.
10. Goode CJ, Titler M, Rakel B, et al. A meta-analysis of effects of heparin flush and saline flush: quality and cost implications. Nurs Res 40:324-330, 1991.
11. Harwood IR, Greene LM, Kozakowski-Koch JA, et al. New peripherally inserted midline catheter: A better alternative for intravenous antibiotic therapy in patients with cystic fibrosis. Pediatr Pulmonol 12:233-239, 1992.
12. Fontaine PJ. Performance of a new softening expanding midline catheter in home intravenous therapy patients. J Intraven Nurs 14:91-99, 1991.
13. Mermel LA, Parenteau S, Tow SM. The risk of midline catheterization in hospitalized patients. A prospective study. Ann Intern Med 123:841-844, 1995.
14. Wilson JN, Grow JB, Demong CV, et al. Central venous pressure in optimal blood volume maintenance. Arch Surg 85:563-578, 1962.
15. Buckley CJ, Lee SD. Placement of vascular access devices for parenteral nutrition. Nutr Clin Pract 14:194-201:1999.
16. Muhm M, Sunder-Plassmann G, Apsner R, et al. Supraclavicular approach to the subclavian/innominate vein for large-bore central venous catheters. Am J Kidney Dis 30:802-808, 1997.
17. Malviya VK, Deppe G, Gove N, et al. Vascular access in gynecologic cancer using the Groshong right atrial catheter. Gynecol Oncol 33:313-316, 1989.
18. Schroder WB. Ultrasound-guided central venous access. Nutr Clin Pract 16:280-283, 2001.
19. Scott WL. Central venous catheters. An overview of Food and Drug Administration activities. Surg Oncol Clin N Am 4:377-393, 1995.
20. Savage AP, Picard M, Hopkins CC, et al. Complications and survival of multilumen central venous catheters used for total parenteral nutrition (TPN). Br J Surg 80:1287-1290, 1993.
21. Bernard RW, Stahl WM. Subclavian vein catheterizatioins; a prospective study. I. Non-infectious complications. Ann Surg 173:184-190, 1971.
22. Smith HO, DeVictoria CL, Garfinkel D, et al. A prospective randomized comparison of an attached silver-impregnated cuff to prevent central venous catheter-associated infection. Gynecol Oncol 58:92-100, 1995.
23. Sitzmann JV, Townsend TR, Siler MC, et al. Septic and technical complications of central venous catheterization. A prospective study of 200 consecutive patients. Ann Surg 202:766-770, 1985.
24. Fong Y, Whalen GF, Hariri RJ, et al. Utility of routine chest radiographs in the surgical intensive care unit. A prospective study. Arch Surg 130:764-768, 1995.
25. Intravenous Nurses Society. Intravenous nursing. Standards of practice. J Intraven Nurs 21:S1-S91, 1998.
26. Gray P, Sullivan G, Ostryzniuk P, et al. Value of postprocedural chest radiographs in the adult intensive care unit. Crit Care Med 20:1513-1518, 1992.
27. CuIIinane DC, Parkus DE, Reddy VS, et al. The futility of chest roentgenograms following routine central venous line changes. Am J Surg 176:283-285, 1998.
28. Riblet JL, Shillinglaw W, Goldberg AJ, et al. Utility of the routine chest X-ray after "over-wire" venous catheter changes. Am Surg 62:1064-1065, 1996.
29. Amshel CE, Palesty JA, Dudrick SJ. Are chest X-rays mandatory following central venous recatheterization over a wire? Am Surg 64:499-501, 1998.
30. Frassinelli P, Pasquale MD, Cipolle MD, et al. Utility of chest radiographs after guidewire exchanges of central venous catheters. Crit Care Med 26:611-615, 1998.
31. Mermel LA. Prevention of intravascular catheter-related infections. Ann Intern Med 132:391-402, 2000.
32. Randolph AG, Cook DJ, Gonzales CA, et al. Benefit of heparin in central venous and pulmonary artery catheters: A meta-analysis of randomized controlled trials. Chest 113:165-171, 1998.
33. Stephens LC, Haire WD, Tarantolo S, et al. Normal saline versus heparin flush for maintaining central venous catheter patency during apheresis collection of peripheral stem cells (PBSC). Transfus Sci 18:187-193, 1997.
34. Deitcher SR, Carman TL. Heparin-induced thrombocytopenia: Natural history, diagnosis, and management. Vase Med 6:113-119, 2001.
35. Lenhart C. Prevention vs. treatment of VAD occlusions. J Vascular Access Devices Winter issue, pp 34-35, 2000.
36. Krzywda EA, Andris DA, Edmiston CE Jr. Catheter infections: Diagnosis, etiology, treatment, and prevention. Nutr Clin Pract 14:178-190, 1999.
37. Maki DG, Cobb L, Garman LK, et al. An attachable silver-impregnated cuff for prevention of infection with central venous catheters: A prospective randomized multicenter trial. Am J Med 85:307-314, 1988.
38. Skiest DJ, Grant P, Keiser P. Nontunneled central venous catheters in patients with AIDS are associated with a low infection rate. J Acquir Immune Dene Syndr Hum Retrovirol 17:220-226, 1998.
39. Rumsey KA, Richardson DK. Management of infection and occlusion associated with vascular access devices. Semin Oncol Nurs 11:174-183, 1995.
40. Stillman RM, Soliman F, Garcia L, et al. Etiology of catheter-associated sepsis. Correlation with thrombogenicity. Arch Surg 112:1497-1499, 1977.
41. Raad II, Luna M, Khalil SA, et al. The relationship between the thrombotic and infectious complications of central venous catheters. JAMA 271:1014-1016, 1994.
42. Timsit JF, Farkas JC, Boyer JM, et al. Central vein catheter-related thrombosis in intensive care patients: Incidence, risks factors, and relationship with catheter-related sepsis. Chest 114:207-213, 1998:.
43. Pinilla JC, Ross DF, Martin T, et al. Study of the incidence of intravascular catheter infection and associated septicemia in critically ill patients. Crit Care Med 11:21-25, 1983.
44. Brun-Buisson C, Abrouk F, Legrand P, et al. Diagnosis of central venous catheter-related sepsis. Critical level of quantitative tip cultures. Arch Intern Med 147:873-877, 1987.
45. Collignon P, Soni N, Pearson I, et al. Sepsis associated with central venous catheters in critically ill patients. Intensive Care Med 14:227-231, 1988.
46. Gil RT, Kruse JA, Thill-Baharozian MC, et al. Triple-vs single-lumen central venous catheters. A prospective study in a critically ill population. Arch Intern Med 149:1139-1143, 1989.
47. Richet H, Hubert B, Nitemberg G, et al. Prospective multicenter study of vascular-catheter-related complications and risk factors for positive central-catheter cultures in intensive care unit patients. J Clin Microbiol 28:2520-2525, 1990.
48. Mermel LA, McCormick RD, Springman SR, et al. The pathogenesis and epidemiology of catheter-related infection with pulmonary artery Swan-Ganz catheters: A prospective study utilizing molecular subtyping. Am J Med 16:197S-205S, 1991.
49. Kemp L, Burge J, Choban P, et al. The effect of catheter type and site on infection rates in TPN patients. JPEN 18:71-74, 1994.
50. Luyt DK, Mathivha LR, Litmanovitch M, et al. Confirmation of the safety of central venous catheterisation in critically ill infants and children -the Baragwanath experience. S Afr Med J 86:603-606, 1996.
51. Charalambous C, Swoboda SM, Dick J, et al. Risk factors and clinical impact of central line infections in the surgical intensive care unit. Arch Surg 133:1241-1246, 1998.
52. Goetz AM, Wagoner MM, Wilier JM, et al. Risk of infection due to central venous catheters: Effect of site of placement and catheter type. Infect Control Hosp Epidemiol 19:842-845, 1998.
53. Prager RL, Silva J Jr. Colonization of central venous catheters. South Med J 77:458-461, 1984.
54. Horowitz HW, Dworkin BM, Savino JA, et al. Central catheter-related infections: Comparison of pulmonary artery catheters and triple lumen catheters for the delivery of hyperalimentation in a critical care setting. JPEN 14:588-592, 1990.
55. Diener JR, Coutinho MS, Aoccoli CM. Central venous catheter-related infections in critically ill patients. Rev Assoc Med Bras 42:205-214, 1996.
56. Williams JF, Seneff MG, Friedman BC, et al. Use of femoral venous catheters in critically ill adults: Prospective study. Crit Care Med 19:550-553, 1991.
57. Durbec O, Viviand X, Potie F, et al. A prospective evaluation of the use of femoral venous catheters in critically ill adults. Crit Care Med 25:1986-1989, 1997.
58. Harden JL, Kemp L, Mirtallo J. Femoral catheters increase risk of infection in TPN patients. Nutr Clin Pract 10:60-66, 1995.
59. Murr MM, Rosenquist MD, Lewis RW 2d, et al. A prospective safety study of femoral vein versus nonfemoral vein catheterization in patients with burns. J Burn Care Rehabil 12:576-578, 1991.
60. Clark-Christoff T N, Watters VA, Sparks W, et al. Use of triple-lumen subclavian catheters for administration of TPN. JPEN 16:403-407, 1992.
61. McCarthy MC, Shives JK, Robison RJ, et al. Prospective evaluation of single and triple lumen catheters in TPN. JPEN 11:259-262, 1987.
62. Farkas JC, Liu N, Bleriot JP. Single-versus triple-lumen central catheter-related sepsis: A prospective randomized study in a critically ill population. Am J Med 93:277-282, 1992.
63. Ma TY, Yoshinaka R, Banaag A, et al. TPN via multilumen catheters does not increase the risk of catheter-related sepsis: A randomized, prospective study. Clin Infect Dis 27:500-503, 1998.
64. Newsome HH Jr, Armstrong CW, Mayhall GC, et al. Mechanical complications from insertion of subclavian venous feeding catheters: Comparison of de novo percutaneous venipuncture to change of catheter over guidewire. JPEN 8:560-562, 1984.
65. Michel LA, Bradpiece HA, Randour P, et al. Safety of central venous catheter change over guidewire for suspected catheter-related sepsis. A prospective randomized trial. Int Surg 73:180-186, 1988.
66. Bonadimani B, Sperti C, Stevanin A, et al. Central venous catheter guidewire replacement according to the Seldinger technique: Usefulness in the management of patients on TPN. JPEN 11:267-270, 1987.
67. Hagley MT, Martin B, Gast P, et al. Infectious and mechanical complications of central venous catheters placed by percutaneous venipuncture and over guidewires. Crit Care Med 20:1426-1430, 1992.
68. Raad II, Hohn DC, Gilbreath BJ, et al. Prevention of central venous catheter-related infections by using maximal sterile barrier precautions during insertion. Infect Control Hosp Epidemiol 15:231-238, 1994.
69. Maki DG, Ringer M, Alvarado CJ. Prospective randomised trial of povidone-iodine, alcohol, and chlorhexidine for prevention of infection associated with central venous and arterial catheters. Lancet 338:339-343, 1991.
70. Hospital Infection Control Practices Advisory Committee. Guideline for prevention of intravascular device-related infections. Part II. Recommendations for the prevention of nosocomial intravascular device-related infections. Am J Infect Control 24:277-293, 1996.
71. Sitges-Serra A, Hernandez R, Maestro S, et al. Prevention of catheter sepsis: The hub. Nutrition 13:30S-35S, 1997.
72. Faubion WC, Wesley JR, Khalidi N, et al. TPN catheter sepsis: Impact of the team approach. JPEN 10:642-645, 1986.
73. Nelson DB, Kien CL, Mohr B, et al. Dressing changes by specialized personnel reduce infection rates in patients receiving central venous parenteral nutrition. JPEN 10:220-222, 1986.
74. Tomford JW, Hershey CO, McLaren CE, et al. Intravenous therapy team and peripheral venous catheter-associated complications. A prospective controlled study. Arch Intern Med 144: 1191-1194, 1984.
75. Abi-Said D, Raad I, Umphrey J, et al. Infusion therapy team and dressing changes of central venous catheters. Infect Control Hosp Epidemiol 20:101-105, 1999.
76. Snyder RH, Archer FJ, Endy T, et al. Catheter infection. A comparison of two catheter maintenance techniques. Ann Surg 208:651-653, 1988.
77. Cook D, Randolph A, Kernerman P, et al. Central venous catheter replacement strategies: A systematic review of the literature. Crit Care Med 25:1417-1424, 1997.
78. Eyer S, Brummitt C, Crossley K, et al. Catheter-related sepsis: Prospective, randomized study of three methods of long-term catheter maintenance. Crit Care Med 18:1073-1079, 1990.
79. Dahlberg PJ, Agger WA, Singer JR, et al. Subclavian hemodialysis catheter infections: A prospective, randomized trial of an attachable silver-impregnated cuff for prevention of catheter-related infections. Infect Control Hosp Epidemiol 16:506-511, 1995.
80. Flowers RH 3d, Schwcnzer KJ, Kopel RF, et al. Efficacy of an attachable subcutaneous cuff for the prevention of intravascular catheter-related infection. A randomized, controlled trial. JAMA 261:878-883, 1989.
81. Hasaniya NW, Angelis M, Brown MR, et al. Efficacy of subcutaneous silver-impregnated cuffs in preventing central venous catheter infections. Chest 109:1030-1032, 1996.
82. Baycos CR, Barrocas A, Webb WR. A prospective randomized trial comparing the silver-impregnated collagen cuff with the bedside tunneled subclavian catheter. JPEN 17:61-63, 1993.
83. Kamal GD, Pfaller MA, Rempe LE, et al. Reduced intravascular catheter infection by antibiotic bonding. A prospective, randomized, controlled trial. JAMA 265:2364-2368, 1991.
84. Maki DG, Stolz SM, Wheeler S, et al. Prevention of central venous catheter-related bloodstream infection by use of an antiseptic-impregnated catheter. A randomized, controlled trial. Ann Intern Med 127:257-266, 1997.
85. Veenstra DL, Saint S, Sullivan SD. Cost-effectiveness of anti-septic-impregenated central venous catheters for the prevention of catheter-related bloodstream infection. JAMA 282:554-560, 1999.
86. George SJ, Vuddamalay P, Boscoe MJ. Antiseptic-impregnated central venous catheters reduce the incidence of bacterial colonization and associated infection in immunocompromised transplant patients. Eur J Anaesthesiol 14:428-431, 1997.
87. van Heerden PV, Webb SA, Fong S, et al. Central venous catheters revisited -infection rates and an assessment of the new Fibrin Analysing System brush. Anaesth Intensive Care 24:330-333, 1996.
88. Ciresi DL, Albrecht RM, Volkers PA, et al. Failure of antiseptic bonding to prevent central venous catheter-related infection and sepsis. Am Surg 62:641-646, 1996.
89. Pemberton LB, Ross V, Cuddy P, et al. No difference in catheter sepsis between standard and antiseptic central venous catheters. A prospective randomized trial. Arch Surg 131:986-989, 1996.
90. Tennenberg S, Lieser M, McCurdy B, et al. A prospective randomized trial of an antibiotic- and antiseptic-coated central venous catheter in the prevention of catheter-related infections. Arch Surg 132:1348-1351, 1997.
91. Bach A, Schmidt H, Bottiger B, et al. Retention of antibacterial activity and bacterial colonization of antiseptic-bonded central venous catheters. J Antimicrob Chemother 37:315-322, 1996.
92. Heard SO, Wagle M, Vijayakumar E, et al. Influcence of triple-lumen central venous catheters coated with chlorhexidine and silver sulfadiazine on the incidence of catheter-related bacteremia. Arch Intern Med 158:81-87, 1998.
93. Collin GR. Decreasing catheter colonization through the use of an antiseptic-impregnated catheter: A continuous quality improvement project. Chest 115:1632-1640, 1999.
94. Hannan M, Juste R, Shankar U, et al. Colonization of triple lumen catheters: A study on antiseptic bonded and standard catheters (abstract). Clin Intensive Care 7:56, 1996.
95. Bach A, Bohrer H, Bottiger BW, et al. Reduction of bacterial colonization of triple lumen catheters with antiseptic bonding in septic patients [Abstract]. Anesthesiology 81:A261, 1994.
96. Ramsay J, Nolte F, Schwarzmann S. Incidence of catheter colonization and catheter related infection with an antiseptic impregnated triple lumen catheter [Abstract]. Crit Care Med 22:A115, 1994.
97. Trazzera S, Stern G, Rakesh B, et al. Examination of antimicrobial coated central venous catheters in patients at high risk for catheter related infections in a medical intensive care unit and leukemia/bone marrow transplant unit [Abstract]. Crit Care Med 23:A152, 1995.
98. Loo S, vanHeerden PV, Gollege CL, et al. Infection in central lines: Antiseptic-impregnated vs standard non-impregnated catheters. Anaesth Intensive Care 25:637-639, 1997.
99. Logghe C, Van Ossel C, D'Hoore W, et al. Evaluation of chlorhexidine and silver-sulfadiazine impregnated central venous catheters for the prevention of bloodstream infection in leukaemic patients: A randomized controlled trial. J Hosp Infect 37:145-156, 1997.
100. Marik PE, Abraham G, Careau P, et al. The ex vivo antimicrobial activity and colonization rate of two antimicrobial-bonded central venous catheters. Crit Care Med 27:1128-1131, 1999.
101. Yasukawa T, Fujita Y, Sari A. Antimicrobial-impregnated central venous catheters. N Engl J Med 340:1762, 1999.
102. Raad I, Darouiche R, Dupuis J, et al. Central venous catheters coated with minocycline and rifampin for the prevention of catheter-related colonization and bloodstream infections. A randomized, double-blind trial. The Texas Medical Center Catheter Study Group. Ann Intern Med 127:267-274, 1997.
103. Raad II, Darouiche RO, Hachem R, et al. Antimicrobial durability and rare ultrastructural colonization of indwelling central catheters coated with minocycline and rifampin. Crit Care Med 26:219-224, 1998.
104. Raad I, Darouiche R, Hachem R, et al. The broad-spectrum activity and efficacy of catheters coated with minocycline and rifampin. J Infect Dis 173:418-224, 1996.
105. Darouiche RO, Raad II, Heard SO, et al. A comparison of two antimicrobial-impregnated central venous catheters. Catheter study group. N Engl J Med 340:1-8, 1999.